Quarterly report pursuant to Section 13 or 15(d)

Operating Segments (Tables)

v3.22.1
Operating Segments (Tables)
3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information

The table below presents certain financial information of our operating segments for the three months ended March 31, 2022 and 2021 (in thousands):

 

Segment Reporting for the Quarter Ended March 31, 2022

 Schedule of Segment Reporting Information

    Treatment     Services     Segments Total     Corporate(1)     Consolidated Total  
Revenue from external customers   $ 7,479     $ 8,436     $ 15,915     $     $ 15,915  
Intercompany revenues     111       183       294              
Gross profit     638       998       1,636             1,636  
Research and development     65       14       79       17       96  
Interest income                       11       11  
Interest expense     (14 )     (1 )     (15 )     (20 )     (35 )
Interest expense-financing fees                       (13 )     (13 )
Depreciation and amortization     371       71       442       14       456  
Segment (loss) income before income taxes     (481 )     285       (196 )     (1,726 )     (1,922 )
Income tax benefit     (559 )     (114 )     (673 )           (673 )
Segment income (loss)     78       399       477       (1,726 )     (1,249 )
Expenditures for segment assets     296       49       345             345 (2)

 

Segment Reporting for the Quarter Ended March 31, 2021

 

    Treatment     Services     Medical     Segments Total     Corporate(1)     Consolidated Total  
Revenue from external customers   $ 7,495     $ 15,638     $   $ 23,133     $     $ 23,133  
Intercompany revenues     660       7             667              
Gross profit     925       1,431             2,356             2,356  
Research and development     47       13       76       136       14       150  
Interest income                             18       18  
Interest expense     (19 )     (8 )           (27 )     (40 )     (67 )
Interest expense-financing fees                             (8 )     (8 )
Depreciation and amortization     310       85             395       5       400  
Segment (loss) income before income taxes     (119 )     555       (76 )     360       (1,415 )     (1,055 )
Income tax benefit     (17 )                 (17 )           (17 )
Segment (loss) income     (102 )     555       (76 )     377       (1,415 )     (1,038 )
Expenditures for segment assets     357       4             361             361 (2)

 

(1) Amounts reflect the activity for corporate headquarters not included in the segment information.
     
(2) Net of financed amount of $114,000 and $29,000 for the three months ended March 31, 2022 and 2021, respectively.